XXXXXXXXX, X. X., Abboussi, O., XXXXXXX, V. X., XXXXXXXX, X. V., & XXXXXXX, X. X. (2017). Epigenetics: a XXXX between XXXXXXXXX XXX XXXXXX XXXXXXXXXXX. XXXXXXXX and Molecular Life XXXXXXXX, XX(15), XXXX-2747.
Belin-Rauscent, A., Fouyssac, X., Bonci, X., & XXXXX, D. (2016). How preclinical XXXXXX XXXXXXX XX resemble the diagnostic XXXXXXXX of XXXX addiction. XXXXXXXXXX psychiatry, 79(X), 39-46.
Best, D., Beckwith, M., XXXXXX, C., Alexander Haslam, S., Jetten, J., Mawson, E., & XXXXXX, D. I. (2016). Overcoming XXXXXXX and XXXXX drug addiction as a process XX social XXXXXXXX transition: XXX XXXXXX identity XXXXX XX XXXXXXXX (SIMOR). Addiction XXXXXXXX &XXX; Theory, 24(2), XXX-XXX.
XXXXXXXXX, X. X. (2017). Communication theory of XXXXXXXXXX: XXXXXXXX adaptive-transformative processes XXXX XXXXXXXX XXXXXXXXXX XXXX and disruption. XX Engaging theories in family communication (pp. 118-129). Routledge.
Everitt, B. J., &XXX; XXXXXXX, T. X. (XXXX). XXXX XXXXXXXXX: updating XXXXXXX XX XXXXXX to XXXXXXXXXXX XXX years on. XXXXXX review of XXXXXXXXXX, 67, XX-XX.
XXXXXXX, X. X., Sherman, M. X., Prenoveau, J. M., &XXX; Chan, X. S. (2016). Item analysis XX the XXXXX Dependence XXXXXXXXXXXXX in XXXXXXXXX treatment centers. XXXXXXXXXXXXX XXXXXXXXXX, XX(9), 1061.
XXXXXXXXX, X. X. (2017). XXX contested place of XXXXXXXXXX in criminological XXXXXX. Challenging XXXXXXXXXXXXXX XXXXXX: The XXXXXX XX XXXX XXXXXX XXXXXXXXXX.
XXXXXX, S. R., XXXXXX, P. J., Schneeberger, S., & Pengel, X. X. (2016). Trial design and XXXXXXXXX in clinical XXXXXXXXXX research. Transplant XXXXXXXXXXXXX, XX(8), 870-879.
McDougall, S. X., XXXXX, X. X., Baum, X. X., XXXXXXX, X. G., &XXX; XXXX, X. (2017). XXXXXXX XX ketamine XX XXX XXXXXXXXXXXXX XXX conditioned locomotor XXXXXXXX XX preadolescent XXX adolescent XXXX: XXXXXX of age, sex, and drug XXXX. Psychopharmacology, XXX(18), 2683-XXXX.
XXXXXXX, X. J. (XXXX). XXXXXXXXXX XXXXXXXXXX XX drug addiction. Neuropharmacology, XX, XXX-XXX.
XXXXXXXXXX, V. I., Rogacheva, L. I., XXXXXX, L. V., XXXXXXX, X. M., XXXXXXX, X. X., & Kolupaev, R. V. (XXXX). Drug XXXXXXXXX XXXXXXXXXX: XXXXXXXXXX of XXXX education institute. XXXX Science Journal, XX(XX), 566.
XXXX, X. X., Ezzati, X., XXXXXXX, S. N., XXXXX, X., Carr, B., & Bukulmez, O. (XXXX). Minimal stimulation in vitro XXXXXXXXXXXXX (XXX) with a XXXXXX-all approach XXXXX XXXXXXXXXX live birth rates in an overall XXXX XXXXXXXXX XXXXXXXXXX. XXXXXXXXX XXX Sterility, XXX(3), e321.
Rolland, B., XXXXXX, F., Gillet, X., Rigaud, X., Moirand, X., XXXX, X., ... &XXX; XXXXX, H. J. (XXXX). Pharmacotherapy XXX alcohol XXXXXXXXXX: XXX 2015 XXXXXXXXXXXXXXX of the French Alcohol XXXXXXX, XXXXXX in partnership XXXX XXX XXXXXXXX Federation of XXXXXXXXX Societies. XXX neuroscience & therapeutics, 22(X), XX-XX.
XXXXXX, N. (XXXX). A XXXX XXXXXX on XXXXXXXXXXXX XX an XXXXX age. XXXXXX J XXXXXXXXXX, 57, XXXX.
XXXXX, A., & XXX, S. (2016). Current XXXXXXX XX XXXXXXX in XXXXXXXXXXX Treatment-X XXXXXXXXXX XXXXXX. XXXXXXXXX Editor, 2(X), XX.
Sirdifield, C., Chipchase, S. Y., XXXX, S., &XXX; Siriwardena, A. N. (XXXX). X XXXXXXXXXX review and meta-synthesis of XXXXXXXX’ experiences XXX XXXXXXXXXXX XX seeking and XXXXX XXXXXXXXXXXXXXX XXX X-XXXXX: towards XXXXX prescribing. XXX XXXXXXX-Patient-XXXXXXXX Outcomes Research, XX(X), X-XX.
Taha, S. (XXXX). Best Practices across XXX XXXXXXXXX of Care for the Treatment XX Opioid Use Disorder.
XXXXXXXXX, S., Sodermans, X. X., Matthijs, K., &XXX; XXXXXXXXX, G. (2014). The effects of XXXXXX XXXX, family relationships and parental role models XX delinquency XXX alcohol use XXXXX XXXXXXX adolescents. XXXXXXX of child XXX XXXXXX studies, XX(1), 128-143.
Weiner, S. G., XXXXXX, L. X., XXXXX, X. X., &XXX; Butler, S. X. (XXXX). X comparison of an opioid XXXXX screening XXXX XXX prescription drug monitoring XXXX in the emergency department. Drug XXX XXXXXXX XXXXXXXXXX, 159, XXX-XXX.